This week the HIV + Hepatitis Policy Institute, a national organization dedicated to promoting quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other chronic conditions, shared recommendations for Delaware’s House Bill 200, currently making it’s way through the legislature.
HB 100 would require health insurance companies (including Medicaid and state employee plans) to cover PrEP (medication taken to prevent infection) and PEP (pills taken after a potential exposure). If this passes, you wouldn’t have to pay out-of-pocket (no copays or deductibles) for these medications, and insurance companies can’t make you wait for “prior authorization” before getting them. The primary sponsor is Nnamdi O. Chukwuocha.
The HIV + Hepatitis Policy Institute shared strong support for the bill while making some specific recommendations to the language. Specifically, they recommended:
- Recommendation 1: Explicitly Require Coverage of All FDA-Approved PrEP Medications
- Recommendation 2: Clarifying Coverage of the Necessary Services to Receive PrEP
- Recommendation 3: Restore the 2027 Effective Date
You can read the entire letter from the Policy Institute below:
Follow our work on HIV/AIDS in Delaware
- Visit our HIV/AIDS Resource page at sussexpride.org/hiv
- Join us on facebook at: HIV Delaware
- Join us on instagram at: HIV Delaware
- Discover HIV /AIDS related organizations on our HIV Resource Page
- Join the Delaware HIV Private Facebook Group